Menglin Wang

No.51 Fucheng Road
Beijing, 100048, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Journal: The Lancet regional health. Western Pacific

Published: July 02, 2026

Long-term efficacy and safety of steroid-eluting sinonasal stents in endoscopic dacryocystorhinostomy: a prospective, single-arm study.

Long-term efficacy and safety of steroid-eluting sinonasal stents in endoscopic dacryocystorhinostomy: a prospective, single-arm study.

Journal: Frontiers in surgery

Published: June 23, 2026

Pollen-Pharmacotherapy Interaction Impacts Symptom Control in Seasonal Allergic Rhinitis.

Pollen-Pharmacotherapy Interaction Impacts Symptom Control in Seasonal Allergic Rhinitis.

Journal: Allergy

Published: February 10, 2026

Mitochondria as key targets underlying hypomagnetic field-induced biological effects.

Mitochondria as key targets underlying hypomagnetic field-induced biological effects.

Journal: iScience

Published: January 15, 2026

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo-Controlled, Phase III Trial.

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo-Controlled, Phase III Trial.

Journal: Allergy

Published: December 17, 2025

Chinese Position Paper on Biologic Therapy for Allergic Rhinitis.

Chinese Position Paper on Biologic Therapy for Allergic Rhinitis.

Journal: Allergy

Published: December 13, 2025

Evaluating stapokibart in the treatment of seasonal allergic rhinitis.

Evaluating stapokibart in the treatment of seasonal allergic rhinitis.

Journal: Immunotherapy

Published: September 03, 2025

Trends and Clinical Features of Pet Sensitization of Allergic Rhinitis from 2017 to 2023 in Beijing, China.

Trends and Clinical Features of Pet Sensitization of Allergic Rhinitis from 2017 to 2023 in Beijing, China.

Journal: International archives of allergy and immunology

Published: January 18, 2025

Correction: Autonomous robotic surgery for zygomatic implant placement and immediately loaded implant-supported full-arch prosthesis: a preliminary research.

Correction: Autonomous robotic surgery for zygomatic implant placement and immediately loaded implant-supported full-arch prosthesis: a preliminary research.

Journal: International journal of implant dentistry

Published: October 07, 2024

Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial.

Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial.

Journal: Nature medicine

Published: August 30, 2024

Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): Rationale and design of a multicentre, randomized, double-blind, placebo-controlled study.

Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): Rationale and design of a multicentre, randomized, double-blind, placebo-controlled study.

Journal: Asia Pacific allergy

Published: April 02, 2024

Human-in-the-loop: Human involvement in enhancing medical inquiry performance in large language models.

Human-in-the-loop: Human involvement in enhancing medical inquiry performance in large language models.

Journal: Allergy

Published: October 15, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026